Form 4: Zura Bio Director Amit Munshi Acquires 117,000 Share Options

Director Amit Munshi of Zura Bio Ltd. has acquired 117,000 share options at an exercise price of $2.76, vesting over one year.

Summary

• Amit Munshi, a director at Zura Bio Ltd., has been granted 117,000 share options.
• The options have an exercise price of $2.76 per share.
• The options vest in twelve equal monthly installments starting from October 23, 2024.
• Any unvested options will vest before the next annual shareholder meeting, contingent on continued service.
• The options expire on December 9, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction of share options to a director, which is generally positive for aligning interests. There are no negative implications.

Positives

• The grant of share options to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment from the director.

Industry Context

The granting of share options to directors is a common practice in the biotechnology industry to incentivize performance and align interests with shareholders.

Comparison to Industry Standards

• Share option grants are a standard form of compensation for directors and executives in publicly traded companies, particularly in the biotech sector.
• The vesting schedule of one year is typical, designed to retain talent and align with company performance milestones.
• The exercise price of $2.76 is a specific value for this grant and would need to be compared to other grants at Zura Bio and similar companies to assess its relative value.

Stakeholder Impact

• Shareholders may view this as a positive sign of aligning director interests with company performance.
• Employees may see this as a standard practice for incentivizing leadership.

Key Dates

Keywords

share options, insider trading, director, Zura Bio, equity, vesting